2021 -now Board Member, Member of Audit Committee @
2023 -2025 Chairman of the Board @
2025 -now Board Member @
2025 -now Chief Financial Officer @
2025 -now Board Member @
2025 -now Partner @
2024 -now Board Member @ Sairiyo Therapeutics Australia Pty Ltd
2024 -now Capital Markets Advisor @
2021 -now Principal @ Kideckel Advisory Group Inc.
2018 -2021 Managing Director | Senior Institutional Equity Research Analyst | Life Sciences @
2017 -2018 Director, Institutional Equity Research Analyst | Healthcare and Biotechnology @
2015 -2017 Medical Scientific Advisor and Senior MSL, Rare Diseases | Hematology and Nephrology @
2014 -2015 Vice President, International Business Development | Ophthalmology and Otolaryngology @
2012 -2014 Director, Business Development @
2012 -2013 Business Development Consultant @
2010 -2012 Various in Sales and Marketing and Medical Affairs @
David Kideckel Education
University of Toronto - Rotman School of Management
MBA (Strategic Management; Innovation & Entrepreneurship)
2011-2014
University of Toronto - Rotman School of Management
Certificate in Medical Device Strategy (Centre for Health Sector Strategy)
2012-2012
McMaster University
MSc (Medical Science)
The University of Winnipeg
BA, BSc (Neuropsychology)
University of Toronto
Doctor of Philosophy - PhD (Neuroscience)
David Kideckel Skills
Corporate Finance
Financial Modeling
Investor Presentations
Market Research
Mergers & Acquisitions (M&A)
Investment Banking
Corporate Development
Capital Raising
Equity Financing
Debt Restructuring
Debt Financing
Operations Management
Finance
International Business Development
Sales
Account Management
Financial Analysis
International Sales
Analytical Skills
Strategic Thinking
Investments
Business Relationship Management
Executive Management
Negotiation
Healthcare Management
New Business Development
Commercialization
Product Management
Product Life Cycle Management
Marketing Strategy
Management Consulting
Venture Capital
Life Sciences
Team Leadership
Pharmaceutical Sales
Biotechnology
Lifesciences
Medical Devices
Science
Research
Competitive Analysis
Start-ups
Business Development
Leadership
Business Strategy
Business Planning
Entrepreneurship
Market Analysis
Strategic Planning
Management
Equity Research
Start Ups
Strategy
Microsoft Office
Microsoft Word
Customer Service
Clinical Research
Project Management
PowerPoint
David Kideckel Summary
David Kideckel, based in Toronto, ON, CA, is currently a Chief Financial Officer at Rakovina Therapeutics. David Kideckel brings experience from previous roles at Pharmadrug Inc. and Kane Biotech Inc.. David Kideckel holds a 2011 - 2014 MBA in Strategic Management; Innovation & Entrepreneurship @ University of Toronto - Rotman School of Management. With a robust skill set that includes Corporate Finance, Financial Modeling, Investor Presentations, Market Research, Mergers & Acquisitions (M&A) and more. David Kideckel has 4 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.